学会発表・講義（国際）

American Urological Association (AUA2022)

May 13-16, 2022 (New Orleans, USA)

Abe T, Ebina K, Hotta K, Higuchi M, Furumido J, Iwahara N, Kon M, Komizunai S, Kurashima Y, Kikuchi H, Matsumoto R, Osawa T, Murai S, Konno A, Shinohara N: Motion Metrics and Machine Learning-based Feedback in Wet-lab Laparoscopic Surgical Training.

American Transplant Congress(ATC2022)

June 4-8, 2022 (Boston, USA)

Hirose T, Ma D, Lassiter G, Sasaki H, Rosales I, Coe TM, Rickert CG, Matheson R, Colvin RB, Qin W, Kan Y, Layer JV, Paragas VB, Stiede K, Hall KC, Youd ME, Queiroz LM, Westlin WF, Curtis M, Yang L, Markmann JF, Kawai T: Long-term (>1 year) Rejection-Free Survival of Kidney Xenotransplantation with Triple Xenoantigen Knockout and Multiple Human Transgenes in Cynomolgus Monkeys.

Kiyohiko Hotta, Takahiro Osawa, Isao Yokota, Tasuku Inao, Tatsu Tanabe, Naoya Iwahara, Nobuo Shinohara: Longitudinal Mortality Risks and Renal Functional Outcomes in Living Kidney Donors.

Kiyohiko Hotta, Naoya Iwahara, Tatsu Tanabe, Nobuo Shinohara: Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.

Naoya Iwahara, Kiyohiko Hotta, Yuki Tanaka, Ikuko Takahashi, Rie Hasebe, Hiromi Okada, Takahiro Tsuji, Yusuke Takada, Haruka Higuchi, Hajime Sasaki, Tatsu Tanabe, Daiki Iwami, Nobuo Shinohara, Masaaki Murakami: Prevention of the progression in chronic calcineurin inhibitors nephrotoxicity via steroidʼs anti-inflammatory effects.

Sasaki H, Harada H, Takamoto D, Takada Y, Harada S, Tanaka H, Tsuji T: Long-term low-dose corticosteroid therapy can suppress calcineurin inhibitor induced nephrotoxicity without steroid-related complication in living kidney transplant recipient.

Sasaki H, Hasegawa K, Miura M, Harada H, Takamoto D, Takada Y, Harada S, Tanaka H: Impaired Humoral Response to second Dose of BNT162b2 mRNA COVID-19 Vaccine in kidney transplant recipients in Japan:Prospective observational study.

Shigeru Harada, Hajime Sasaki, Yusuke Takada, Daiji Takamoto, Tetsuo Hirano, Hiroshi Harada, Hiroshi Tanaka: Evaluation of renal function after donation in living marginal kidney donor.

Shigeru Harada, Hajime Sasaki, Yusuke Takada, Daiji Takamoto, Tetsuo Hirano, Hiroshi Harada, Hiroshi Tanaka: Suppressive effect of de novo everolimus on primary cytomegalovirus infection in kidney transplant recipient.

International continence society （ICS2022）

September 6-10, 2022 (Vienna, Austria)

Chiba H, Kitta T, Higuchi M, Kusakabe N, Kon M, Nakamura M, Shinohara N: Ureteral reimplantation during augmentation cystoplasty is not needed for vesicoureteral reflux in patients with neurogenic bladder: A long-term retrospective study.

Abe-Takahashi Y, Kitta T, Ouchi M, Chiba H, Higuchi M, Togo M, Kusakabe N, Shinohara N: Histological examination of Pelvic Floor Muscle in a Rat Model of Vaginal Delivery.

The Transplantation Symposium

September 12, 2022 (Buenos Aires, Argentina)

Hirose T, Sasaki H, Oura T, Ma D, Lassiter G, Dehnadi A, Hanekamp I, Rosales I, Colvin RB, Cosimi AB, Cippà PE, Fehr T, Kawai T: Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppressive complications.

Hirose T, Ma D, Lassiter G, Kawai T: Successful induction of hematopoietic chimerism by dual inhibition of MCL-1 and Bcl-2 without myeloablative treatments in nonhuman primates.

Transplantation Science Symposium Asian Regional Meeting 2022

November 25-26, 2022 (Kyoto, Japan)

Hotta K: Development of immunomonitoring system to predict chronic active antibody-mediated rejection in kidney transplant recipients.

Iwahara N, Hotta K, Hirose T, Shinohara N: Late conversion to a calcineurin inhibitor-free regimen with everolimus after renal transplantation.

Iwahara N, Hotta K, Hirose T, Shinohara N: Novel mixed lymphocyte reaction assay that predicts chronic antibody mediated rejection in kidney transplant.

Sasaki H, Tanabe T, Higuchi H, Tsujimoto T, Harada H: Initial reduction of tacrolimus with additional everolimus may not prevent early acute rejection.

Hirose T, Hotta K, Osawa T, Yokota I, Inao T, Tanabe T, Iwahara N, Shinohara N: Longitudinal mortality risks and renal functional outcomes in Japanese living kidney donors.

Hirose T: Mechanisms and Utility of IVIG in Kidney Transplantation